ARCA Biopharma Inc Stock Price. Everything You Need To Know About The ARCA Biopharma Inc Stock! ARCA Biopharma Inc Stock Price. Everything You Need To Know About The ARCA Biopharma Inc Stock!


ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company based in Broomfield, Colorado. With 5 full-time employees, the company went IPO on July 21st, 2000. ARCA biopharma is dedicated to the development and commercialization of targeted therapies for cardiovascular diseases.

The firm’s lead product candidate is Gencaro (bucindolol hydrochloride), which is being developed for the treatment of atrial fibrillation (AF) in patients with chronic heart failure (HF). Gencaro is a pharmacogenetically-targeted beta-adrenergic receptor antagonist with mild vasodilator properties. The company is developing Gencaro for patients who have a genotype that identifies a drug target associated with heightened efficacy.

In addition to Gencaro, ARCA biopharma is also developing a protein therapeutic known as Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201) for the potential treatment of COVID-19. The rNAPc2 is currently in a phase IIb clinical trial as a potential treatment for patients hospitalized with COVID-19.

As a potential investor, it’s important to keep an eye on ARCA biopharma’s ongoing clinical trials, including those related to Gencaro and rNAPc2. This will help you stay up to date with the company’s latest developments and its potential for growth. By monitoring the stocks share price today, premarket, and market cap, you can gain valuable insights into the company’s performance and potential for investment. However, investing in a clinical-stage biopharmaceutical company involves a certain level of risk, and thorough research is necessary to make informed investment decisions.



ARCA Biopharma Inc Stock Price. Everything You Need To Know About The ARCA Biopharma Inc Stock! performance

  • Employees 5
  • Company HQ Broomfield
  • Website http://arcabio.com/
  • ABIO Asset Type Common Stock
  • ABIO Market Capitalization 51.9M
  • Earnings Per Share -0.42
  • Dividends Per Share None
  • Dividend Date 2019-04-04
  • Quarterly Earnings Growth 0

Are you an investor from Malaysia, Thailand, Indonesia or Vietnam looking to invest in the stock market? Look no further than ARCA Biopharma. As a content marketing expert at Zorion, an investment platform, we understand the importance of making informed investment decisions. ARCA Biopharma is an excellent choice for retail investors looking to tap into the biopharmaceutical industry. With its potential for groundbreaking discoveries and profitable growth, investing in ARCA Biopharma can be a game-changer for your investment portfolio. At Zorion, we offer investment insights and recommendations to help investors from Malaysia, Thailand, Indonesia, and Vietnam navigate the stock market. Our resources and educational materials are designed to further enhance your knowledge and understanding of the stock market. Explore our platform today and learn how to invest in ARCA Biopharma.


Want To Buy ARCA Biopharma Inc Stock From Malaysia, Indonesia, Thailand or Philippines? You may also be interested in: